Jan 9 (Reuters) - Nasdaq on Friday said U.S. retailer Walmart will replace British drugmaker Astrazeneca in the Nasdaq-100 Index effective on January 20, 2026.

(Reporting by Rhea Rose Abraham in Bengaluru; Editing by Tom Hogue)